Trial intelligence / Profile preview

Dexmedetomidine added to WALANT for distal radius fracture surgery

IRCT20250722066589N3Phase 2Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Aug 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of dexmedetomidine in distal forearm fracture (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Block duration, Onset of block and 4 more. Started Aug 2025; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

distal forearm fracture

Beyond the preview

Go deeper on IRCT20250722066589N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20250722066589N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call